Asthma Clinical Trials in Colorado Springs, Colorado

5 studies are recruiting for asthma in Colorado Springs, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

   The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   GSK Investigational Site, Colorado Springs, Colorado

   Locations

   67 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT05757102 on ClinicalTrials.gov

2. A Study of Depemokimab in Participants of 6 to 11 Years of Age

   This study is aimed at assessing depemokimab as an add-on medicine for the treatment of asthma with type-2 inflammation in participants of 6 to 11 years of age. This study will test how the body processes depemokimab, how the drug works in the body, and its safety and tolerability.

   Stage

   Phase 3

   Ages

   6 to 11

   Site

   GSK Investigational Site, Colorado Springs, Colorado

   Locations

   3 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT07671001 on ClinicalTrials.gov

3. A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

   The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma. Study participation will last approximately 65 weeks, including screening, treatment, and follow-up periods.

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Asthma & Allergy Associates - Colorado Springs, Colorado Springs, Colorado

   Locations

   121 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219173 on ClinicalTrials.gov

4. ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

   This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants w…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Enveda Investigative Site, Colorado Springs, Colorado

   Locations

   18 in total

   Run by

   Enveda Therapeutics

   See if you can join NCT07301255 on ClinicalTrials.gov

5. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

   The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning o…

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   Colorado ENT & Allergy, Colorado Springs, Colorado

   Locations

   132 in total

   Run by

   Pfizer

   See if you can join NCT06977581 on ClinicalTrials.gov